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We investigated the role of interferon gamma (IFN-g) in a mouse model of immunity to vaginal infection by herpes simplex
virus type 2 (HSV-2). Within 8 h after immune mice were challenged intravaginally with HSV-2, IFN-g concentrations in vaginal
secretions reached levels that can be antiviral in vitro. This rapid synthesis of IFN-g occurred in immune-challenged mice but
not in nonimmune-challenged mice, indicating that it required memory T cells. Immunostaining and in situ hybridization
revealed that the IFN-g was synthesized by cells whose morphological appearance suggested that they were lymphocytes
and macrophage-like cells in the mucosa. The presence of IFN-g in vaginal secretions was correlated with upregulation of
MHC class II antigens in the epithelium and with vigorous (30-fold) recruitment of T and B lymphocytes into the vagina. In
vivo administration of anti-IFN-g to immune mice 17 h before virus challenge blocked the subsequent appearance of IFN-g
in vaginal secretions, blocked upregulation of class II antigens, blocked adherence of T cells to endothelium and their
recruitment into the vagina, and markedly reduced immunity against reinfection of the vaginal epithelium. © 1999 Academic Press
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iINTRODUCTION
An understanding of the immune mechanisms that
rotect the female genital tract against infections in an-
mal models is essential for development of vaccines to
rotect women against sexually transmitted diseases
Parr and Parr, 1999). A mouse model of immunity
gainst vaginal herpes simplex virus type 2 (HSV-2) in-
ection has been described by McDermott and co-work-
rs (1984) and modified by Parr et al. (1994). In this
odel, vaginal immunization with attenuated HSV-2 elic-
ts immunity against a subsequent vaginal challenge
ith wild-type virus. The protective immunity in this
odel is quite strong (Parr and Parr, 1998a; Parr and Parr,
998b). Twenty-four hours after immune mice were chal-
enged in the vagina with wild-type virus, infection of the
aginal epithelium ranged from 0.0 to 2.5% of that mea-
ured in nonimmune mice, and at 72 h after vaginal
hallenge, no shed virus protein was detected in the
aginal lumen of immune mice whereas shed virus pro-
ein titers of 5000–6000 were present in nonimmune
ice. No immune mice developed neurological illness,
hereas nearly all nonimmune mice died 8–14 days after
hallenge. The dose of challenge virus used in these
tudies was 1000-fold higher than the minimum needed
o cause lethal illness in nonimmune mice, thus vigorous
mmunity was needed to suppress the challenge infec-
ions so effectively. The data suggested that local im-
1 To whom reprint requests should be addressed. Fax: (618) 453-
t527. E-mail: mparr@som.siu.edu.
042-6822/99 $30.00
opyright © 1999 by Academic Press
ll rights of reproduction in any form reserved.
282une mechanisms in the vaginal mucosa were impor-
ant in this protection because replication of challenge
irus in the vaginal epithelium was rapidly and effectively
nhibited in the immune mice.
Antibody in vaginal secretions is an important compo-
ent of immunity to vaginal HSV-2 infection (Parr and
arr, 1997). Affinity-purified IgG from vaginal secretions
f adult immune mice, at its concentration in vivo in the
aginal mucus, effectively neutralized HSV-2, and puri-
ied IgG from serum of immune mice provided significant
rotection against epithelial infection after passive trans-
er to nonimmune mice. An involvement of cell-mediated
mmunity in the mouse vaginal HSV-2 model was first
ndicated by the observation that adoptive transfer of
ymphocytes from the iliac lymph nodes of immune mice
rotected naive mice against neurological illness after
aginal challenge with wild-type virus (McDermott et al.,
987). We further investigated the role of T cells in vag-
nal immunity by in vivo depletion of these cells in im-
une mice 1 week before vaginal challenge (Parr and
arr, 1998b). Acute depletion of T cells for this short
eriod had no effect on antibody titers in vaginal secre-
ions at the time of challenge. The results showed that
mmune mice depleted of CD41 and CD81 cells,
hy-11 cells, or CD81 cells alone had greater viral
nfection of the vaginal epithelium 24 h after challenge
han did nondepleted immune mice. The T cells of im-
unized mice thus acted rapidly to protect the vaginal
pithelium against infection by the challenge virus. Sim-
lar results have been reported by Milligan et al. (1998).
The protective effect of T cells against numerous in-racellular pathogens is partly due to their secretion of
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283ROLE OF IFN-g IN IMMUNITY TO VAGINAL HSV-2 INFECTIONamma interferon (IFN-g) after activation by antigen
Buchmeier and Schreiber, 1985; Li et al., 1987; Suzuki et
l., 1988; Squires et al., 1989; Zhong et al., 1989; Ramsay
t al., 1993; Cantin et al., 1995). In the mouse vaginal
SV-2 model, IFN-g is probably secreted in the vaginal
ucosa of immune mice after virus challenge because
HC class II antigens in vaginal epithelial cells were
pregulated (Parr et al., 1994), and it is well known that
FN-g is a potent inducer of class II antigens (Steeg et al.,
982; Pober et al., 1983; Basham et al., 1985; Bland, 1988).
oreover, Milligan and co-workers (Milligan and Bern-
tein, 1997; Milligan et al., 1998) have shown that IFN-g is
nvolved in clearance of HSV-2 from the vagina of non-
mmune mice and in resistance to reinfection in immune
ice. In the present study, we have further investigated
he role of IFN-g in immunity to vaginal HSV-2 infection.
n particular, we measured the concentration of IFN-g in
he vaginal lumen of immune mice after challenge as an
ndication whether it may have antiviral activity in the
djacent epithelial layer and localized it in the vaginal
ucosa by immunostaining and in situ hybridization. We
lso determined the time course of IFN-g secretion after
irus challenge in both immune and nonimmune mice
nd correlated that secretion to the expression of MHC
lass II antigens in the epithelium and to the numbers of
and B lymphocytes in the mucosa. Finally, we evalu-
ted in vivo neutralization of IFN-g by administration of
onoclonal antibody and the effects of such neutraliza-
ion on upregulation of epithelial MHC class II antigens,
n recruitment of lymphocytes to the vagina, and on
mmunity to reinfection of the epithelium by HSV-2. The
esults of these studies demonstrate an important role
or memory T cells and IFN-g in the early stages of
esistance to challenge virus infection of the vaginal
pithelium.
RESULTS
FN-g in vaginal secretions
The concentrations of IFN-g in extracts of vaginal
ucus from individual mice were measured by chemilu-
inescence ELISA (Table 1). IFN-g was not detectable in
aginal secretions from nonimmune or immune mice, but
t was readily detected 20 h after immune mice were
hallenged in the vagina with wild-type HSV-2. The
LISA reaction for IFN-g in the latter vaginal samples
as inhibited 90% by addition of rat monoclonal anti-
ouse IFN-g at 100 ng/ml, indicating specificity for
FN-g. Based on a mean concentration of 150 pg/ml in
he extracts of vaginal mucus from immune-challenged
ice and a 15-fold dilution during extraction, the concen-
ration of IFN-g in situ in the vaginal secretions of theseice was ;2.0 ng/ml. mFN-g in vaginal mucosa
The source (s) of IFN-g in vaginal secretions was
nvestigated by immunostaining and in situ hybridization.
mmunostaining of IFN-g was observed in clusters of
rregularly shaped, macrophage-like cells located just
nder the vaginal epithelium at 24 h after immune mice
ere challenged (Figs. 1a and 1b). Little or no staining
as detectable in macrophage-like cells in the remain-
er of the stroma. IFN-g was also observed in smaller
ells that appeared to be lymphocytes within the clusters
f macrophage-like cells and in similar cells scattered
hroughout the stroma. No staining was present in these
ections when irrelevant rabbit antisera were substituted
or rabbit anti-mouse IFN-g serum (Fig. 1c), and staining
as markedly inhibited when anti-IFN-g serum was neu-
ralized with recombinant IFN-g before application to the
ections. Also no staining of IFN-g was detectable in
ections from immune-nonchallenged mice or in sec-
ions from nonimmune mice at 24 h after challenge.
Using high-stringency conditions of in situ hybridiza-
ion, IFN-g mRNA was observed in clusters of macro-
hage-like cells located just under the vaginal epithelium
Fig. 2a) and in similar cells scattered throughout the
troma in immune mice at 24 h after challenge. IFN-g
RNA was also observed in lymphocyte-like cells that
ere arranged in clusters or scattered throughout the
troma and in similar cells in the basal region of the
pithelium (Fig. 2a). Little or no nonspecific staining was
bserved when the sense probe was used on these
ections (Fig. 2b) or when antisense probe was used on
ections from immune-nonchallenged mice or nonim-
TABLE 1
IFN-g in Vaginal Secretionsa
Mice IFN-g (pg/ml)b
Nonimmune 0.44 6 0.64c
Immuned 20.88 6 0.55e
Immune/challenged f 150 6 14g
a The cytokine was measured in 200 ml extracts of vaginal mucus
rom individual mice. Because the vaginal mucus is 97% water and
verages 10–15 ml per mouse (Parr et al., 1998), the cytokine concen-
rations in the vaginal mucus in situ were ;15 fold higher than values
easured in the extracts.
b Ten mice per group.
c Not significantly different from 0.0, P 5 0.51, two-tailed Student’s t
est.
d Six weeks after vaginal immunization with attenuated HSV-2 at
.5 3 106 PFU/ml.
e Not significantly different from 0.0, P 5 0.15, two-tailed Student’s t
est.
f Twenty hours after immune mice were challenged in the vagina with
ild-type HSV-2 at 3.5 3 106 PFU/ml.
g Significantly greater than 0.0, P , 0.0001, one-tailed Student’s t test.une-challenged mice.
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285ROLE OF IFN-g IN IMMUNITY TO VAGINAL HSV-2 INFECTIONime course of IFN-g secretion
The concentration of IFN-g in vaginal secretions of
mmune mice increased rapidly after vaginal challenge
ith wild-type virus, reaching maximum levels within 8 h
nd then declining slowly to a low level at 96 h after
hallenge (Table 2). The IFN-g concentration in the su-
erficial vaginal mucosa thus exceeded 1.0 ng/ml within
h after challenge and remained above that level for
24 h. Upregulation of MHC class II antigens in vaginal
pithelial cells lagged behind IFN-g concentrations, be-
oming detectable at 16 h and reaching maximum at
4–32 h after challenge (Fig. 3a). The numbers of lym-
hocytes in the vaginal mucosa also increased rapidly
fter vaginal challenge, being significantly increased at
h and reaching near maximum levels by 24 h after
hallenge (Figs. 4a, 4c, and 4e). In nonimmune mice,
FN-g was not detectable in vaginal secretions until 48 h
fter challenge (Table 3). At this time T and B cell num-
ers were not increased in the vagina, and MHC class II
ntigens were just beginning to appear in vaginal epi-
helial cells. The contrasting results in immune and non-
mmune mice strongly suggest that memory T cells in the
agina of immune mice responded to the challenge virus
ntigen by rapid secretion of IFN-g and that some aspect
f the memory T cell response also upregulated MHC
FIG. 1. Immunolabeling of IFN-g (a and b) in the vagina of immune m
aginal stroma in cells that morphologically resemble lymphocytes (b, a
n the vaginal epithelium (a, short arrow). No labeling was observed w
erum (c). The epithelium appears to be thicker in (c) than in (a) and (b)
250 (a), 3500 (b), and 3250 (c).
FIG. 2. In situ hybridization of IFN-g mRNA identified by a biotinylated
esemble lymphocytes (a, arrowheads) and in macrophage-like cells (a,
irus. No hybridization was detectable with the sense version of the IFN
T
Time Course of IFN-g Secre
Timea
(h)
IFN-gb
(pg/ml) MHC class IIc
0 0.7 6 0.7 0.0 6 0.0
8 191 6 15.0 0.0 6 0.0
16 139.0 6 15.0 1.3 6 0.2
24 81.0 6 8.0 2.7 6 0.2
32 61.0 6 12.0 3.0 6 0.0
48 22.0 6 6.5 1.6 6 0.2
96 7.6 6 2.0 0.4 6 0.1
a Time after vaginal challenge with wild-type HSV-2. A total of 57 mi
b IFN-g concentration in 200-ml extracts of vaginal mucus (mean 6
c Staining of vaginal epithelial cells on a scale of 0–3. One section f
d Numbers of lymphocytes per high power microscopic field of vag
istological sections from two blocks from each mouse were counted. T
ere significantly larger than the numbers present at 0 h (P 5 0.0017,agnifications: 3250 (a) and 3250 (b).lass II antigens in the epithelium and caused vigorous
ecruitment of T and B lymphocytes into the vagina.
eutralization of IFN-g in vivo
Administration of $0.3 ml of anti-IFN-g ascites to
mmune mice 17 h before vaginal challenge effectively
eutralized or eliminated IFN-g in vaginal secretions
4 h after challenge and blocked upregulation of MHC
lass II antigens in the vaginal epithelium (Table 4; Fig.
b). Unexpectedly, the in vivo neutralization of IFN-g
lso completely blocked recruitment of T cells to the
agina and diminished recruitment of B cells while
aving no apparent effect on neutrophils (Figs. 4b, 4d,
nd 4f). Local IFN-g secretion by memory T cells in the
agina after antigen challenge was thus required for
ecruitment of additional lymphocytes to the vagina.
he effect of IFN-g on recruitment of lymphocytes to
he vagina involved the vascular endothelium because
any lymphocytes were adherent to the endothelium
n immune-challenged mice without ascites treatment
Fig. 5), but negligible adherent T cells and few B cells
ere present in small veins of immune-challenged
ice treated with either 0.3 or 1.0 ml of ascites (Figs.
b, 4d, and 4f).
h after ivag challenge with wild-type virus. Labeling is present in the
ds), in macrophage-like cells (b, long arrows), and in unidentified cells
relevant rabbit antisera were substituted for rabbit anti-mouse IFN-g
e this section is more tangential to the epithelial layer. Magnifications:
se RNA IFN-g probe. Signal was detected in cells that morphologically
) in the vagina of immune mice 1 day after ivag challenge with wild-type
e used as a control on sections of the same tissues (b). E, epithelium.
Immune-Challenged Mice
Lymphocytesd
CD41 CD81 B2201
0.36 6 0.07 0.04 6 0.04 0.8 6 0.33
5.61 6 1.02 1.39 6 0.39 6.23 6 1.05
8.9 6 1.7 3.5 6 0.99 8.6 6 1.5
7.7 6 0.4 6.4 6 0.6 14.2 6 1.8
8.4 6 0.8 8.3 6 0.6 14.5 6 2.0
6.6 6 0.8 4.6 6 0.87 16.3 6 2.9
3.4 6 1.0 1.5 6 0.2 11.9 6 2.8
e used with 5–10 mice at each time point.
rd error of mean).
ch of two blocks from each mouse were examined.
oma (mean 6 standard error of mean). Five fields from each of two
bers of CD41, CD81, and B2201 lymphocytes at 8 h after challenge
.016, and P 5 0.0018, respectively, one-tailed t tests).ice 24
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286 PARR AND PARRffects of in vivo neutralization of IFN-g on immunity
o epithelial infection
As expected from the results in Table 4, administration
f 0.5 ml of anti-IFN-g ascites to immune mice 17 h
efore challenge neutralized or eliminated IFN-g in vag-
nal secretions after challenge and blocked upregulation
f MHC class II antigens in the vaginal epithelium (Table
). Similarly, in vivo neutralization of IFN-g again blocked
dherence of T cells to the vascular endothelium,
locked recruitment of both CD41 and CD81 T cells into
he vaginal mucosa, and reduced recruitment of B cells.
scites treatment had no significant effect on IgG anti-
SV-2 titers in vaginal secretions at 24 h after challenge
ut caused a small increase in antibody titers at 52 h
fter challenge. Virus protein shedding from the vaginal
pithelium of immune mice after challenge was markedly
ncreased by in vivo neutralization of IFN-g as evidenced
y increased concentrations of shed virus proteins in the
aginal secretions of ascites-treated mice at both 24 and
2 h after challenge. However, all immunized mice re-
ained immune to lethal neurological disease. Thus
ntibody and possibly other immune mechanisms that
emained effective after in vivo neutralization of IFN-g
ere sufficient to prevent neurological disease. This
llustrates clearly that if the intent of an experiment is to
valuate the immune mechanisms that act at the muco-
al surface to prevent challenge infection of the vaginal
pithelium, then a direct measure of epithelial infection
s employed here is more informative than neurological
isease.
DISCUSSION
IFN–g was detected in the vaginal secretions within
h after immune mice were challenged in the vagina
ith HSV–2. At 24 h after challenge, the cytokine was
FIG. 3. Immunolabeling of MHC class II antigens in the vaginal epi
mmune mice were pretreated with anti-IFN-g before challenge, labeling
n stromal dendritic cells. L, vaginal lumen. Magnifications: 3350 (a) aocalized in the vaginal mucosa by in situ hybridization Snd immunostaining in cells having the morphology of
ymphocytes and macrophages; further studies are
eeded to clarify the identity of these cells. After secre-
ion in the mucosa, the cytokine probably passed into the
aginal lumen by transudation and accumulated in the
ucus that is secreted by the vaginal epithelium. Be-
ause the volume of the mucus secretion in the vaginal
umen is known (Parr et al., 1998), we were able to
alculate the concentration of IFN–g in situ in the vaginal
umen. This concentration exceeded 1.0 ng/ml (10 IU/ml)
etween 8 and 32 h after challenge, and the concentra-
ion in the mucosa was presumably higher than in the
umen. In a similar study, Milligan and colleagues (1998)
eported IFN–g concentrations in the vaginal lumen that
ere higher than those reported here. IFN–g concentra-
ions of ;10 IU/ml have been found to inhibit replication
f several kinds of viruses in diverse target cells in vitro
Babiuk and Rouse, 1976; Koyanagi et al., 1988; Mestan
t al., 1988; Kornbluth et al., 1989; Croen, 1993; Karupiah
t al., 1993). While many possibilities exist for synergism
r antagonism between IFN–g and other cytokines in
ivo, the data are consistent with a suggestion that IFN–g
ight directly inhibit the replication of sexually transmit-
ed intracellular pathogens such as HSV–2, human pap-
llomaviruses, human immunodeficiency virus–1, and
hlamydia trachomatis in the cervix or vagina of appro-
riately immunized humans. We observed that virus
hedding in the vagina of immune-challenged mice was
ubstantially increased when IFN–g was neutralized in
ivo with monoclonal antibody, but it is important to
ecognize that this could be due to the inhibition of T cell
ecruitment to the vagina rather than to inhibition of
irect antiviral effects. It has been suggested that direct
ntiviral effects of IFN–g in vivo may be less important
han immunoregulatory effects (Nathan, 1992; Farrar and
of immune mice 24 h after challenge with wild-type virus (a). When
etected only in Langerhans cells (b, arrowheads) in the epithelium and
50 (b).thelium
was dchreiber, 1993), but this is based almost entirely on the
i
(
fFIG. 4. Fluorescence micrographs showing immunolabeling of CD41 T cells (a, arrows), CD81 T cells (c, arrows), and B2201 B cells (e, arrows)
n the vaginal stroma of immune mice 24 h after ivag challenge with wild-type virus. Little or no labeling of CD41 (b), CD81 (d), and B2201 cells
f) was observed in the vaginas of immune-challenged mice that were treated with anti-IFN-g 17 h before challenge. Nonspecific staining is due to
luorescence of granulocytes. E, epithelium. Arrowheads, blood vessels. Magnifications: all 3350.
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288 PARR AND PARRlearance of primary infections rather than on immunity
gainst challenge infections.
Memory T cells are distinguished from naive T cells
ainly by their more rapid and vigorous response to
ntigen, including their cytokine secretory response (Mu-
ali-Krishna et al., 1998). The present demonstration that
FN–g was rapidly secreted (,8 h) in the vagina in
esponse to virus challenge in immune mice but not in
onimmune mice thus provides cogent in vivo evidence
hat functional, virus–specific memory T cells were
resent in the vagina at the time of challenge. Our results
n vivo are analogous to early in vitro studies showing
hat T lymphocytes from immune humans (Valle et al.,
975) and cows (Babiuk and Rouse, 1976), when cultured
ith macrophages and antigen, secreted IFN–g into the
edium in as little as 8 h, whereas T cells from nonim-
une individuals did not produce IFN–g. This interpre-
ation of the kinetic data is consistent with the theory that
emory T cells preferentially recirculate from blood to
ymph via nonlymphoid tissues, whereas naive T cells
T
Time Course of IFN-g Secreti
Timea
(h)
IFN-gb
(pg/ml) MHC class IIc
0 5.4 6 11.4 0.0 6 0.0
24 1.3 6 11.5 0.0 6 0.0
32 25.5 6 11.7 0.0 6 0.0
48 250 6 34 0.11 6 0.05
96 290 6 60 0.88 6 0.25
a Time after vaginal challenge with wild-type HSV-2. A total of 40 mi
b IFN-g concentration in 200-ml extracts of vaginal mucus (mean 6 s
rom 0.0 (two-tailed t tests).
c Staining of vaginal epithelial cells on a scale of 0–3. One section f
d Numbers of lymphocytes per high power microscopic field of vag
ections from two blocks from each mouse were counted.
T
Neutralizatio
Anti-IFN-ga
(ml)
IFN-gb
(pg/ml) MHC class IIc
0.0 110 6 18 3.0 6 0.0
0.1 9.9 6 2.0 0.004 6 0.003
0.3 3.8 6 1.4 0.0 6 0.0
1.0 20.7 6 1.0 0.0 6 0.0
a Anti-IFN-g ascites was injected ip into immune mice 17 h before vag
nd 2.0 mg of rat IgG anti-mouse IFN-g, respectively. A total of 37 mic
b IFN-g concentration in 200 ml extracts of vaginal mucus 24 h after
c Staining of vaginal epithelial cells on a scale of 0–3 (mean 6 stan
as examined.
d Numbers of lymphocytes per high power microscopic field of vagections from two blocks from each mouse were counted.referentially recirculate via lymph nodes (Mackay, 1991).
e have shown that many if not most of the T cells that
ontinuously traffic from the superficial vaginal mucosa
o the iliac lymph nodes of both immune and nonimmune
ice bear the memory T cell marker, CD44 (King et al.,
998). Further evidence that memory T cells in the vagina
elong to the recirculating pool comes from the obser-
ation that vaginal challenge elicited rapid upregulation
f MHC class II antigens and recruitment of lymphocytes
o the vagina in parenterally immunized mice (Parr and
arr, 1998a) and rapid secretion of IFN-g in nasally im-
unized mice (Parr and Parr, unpublished observations).
lso, virus–specific effector T cells have been demon-
trated in the female reproductive tract (Lohman et al.,
995; Milligan and Bernstein, 1995). Our present results
omplement a report that the IFN-g response to HSV-2
hallenge in this immune mouse model was abrogated
y in vivo depletion of T cells with anti-Thy-1 antibody
Milligan et al., 1998). Because virus shedding in the
agina of immune mice after challenge was substantially
onimmune-Challenged Mice
Lymphocytesd
CD41 CD81 B2201
0.32 6 0.22 0.14 6 0.04 0.50 6 0.09
0.32 6 0.15 0.16 6 0.15 0.36 6 0.16
0.02 6 0.06 0.16 6 0.04 0.26 6 0.07
0.50 6 0.20 0.12 6 0.05 0.48 6 0.10
2.24 6 1.26 0.62 6 0.26 1.64 6 0.83
e used with 5–10 mice at each time point.
error of mean). Values at 0, 24, and 32 h are not significantly different
ch of two blocks from each mouse was examined.
oma (mean 6 standard error of mean). Five fields from each of two
N-g in Vivo
Lymphocytesd
CD41 CD81 B2201
6.7 6 1.1 6.1 6 0.7 11 6 1.0
2.2 6 0.8 1.8 6 0.4 3.5 6 0.6
0.2 6 0.2 0.5 6 0.2 5.4 6 1.8
0.0 6 0.0 0.1 6 0.1 5.1 6 1.4
allenge with HSV-2. The monoclonal antibody doses were 0.0, 0.2, 0.6,
used with 9–10 mice in each group.
nge with wild-type virus (mean 6 standard error of mean).
ror of mean). One section from each of two blocks from each mouse
oma (mean 6 standard error of mean). Five fields from each of twoABLE 3
on in N
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289ROLE OF IFN-g IN IMMUNITY TO VAGINAL HSV-2 INFECTIONncreased when IFN–g was neutralized in vivo, it is ap-
arent that the virus-specific memory T cells that recir-
ulate through the vagina play a key early role in muco-
al immunity to vaginal HSV–2 infection even if their only
unction is that of rapid IFN–g secretion in response to
ntigen challenge.
The early involvement of memory T cells in immunity
gainst vaginal reinfection by HSV–2 emphasizes the
mportance of factors that may influence the numbers of
emory lymphocytes in the vagina after immunization
ut before challenge. A particularly important consider-
tion is whether the site of immunization affects the
umbers of either sessile or recirculating memory T cells
n the vagina. Studies of the intestine and skin have
uggested that memory lymphocytes that were activated
n those locations later recirculated preferentially
hrough those tissues (Mackay et al., 1992; Picker and
utcher, 1992; Mackay, 1994). This suggests that local
mmunization in the vagina might result in greater num-
ers of memory lymphocytes in the vagina than would be
enerated by an otherwise equivalent immunization at a
arenteral site. In a recent comparison of vaginal and
arenteral immunization with attenuated HSV–2, we
ound only a modest difference in the numbers of T and
lymphocytes in the vagina of the immune mice before
irus challenge and little difference in recruitment of
ymphocytes to the vagina after challenge (Parr and Parr,
998a). Vaginal lymphocyte numbers were approximately
wofold higher in vaginally immunized mice than in the
arenteral groups, but serum antibody titers were also
wofold higher in the vaginally immunized mice, suggest-
FIG. 5. Fluorescence micrographs showing immunolabeling of CD41
lood vessels in the vaginal stroma of immune mice 24 h after ivag ch
ndothelium lining the blood vessels. E, epithelium. Magnifications: alng a more efficient immunization at this site and possi- cly a greater proliferation of lymphocytes. Another pos-
ibility is that lymphocyte homing and recruitment in the
agina may be influenced by steroid hormones. All mice
n the present study were treated with a progestin, and
omparisons with estrogen treatment or other treat-
ents remain to be explored.
Previously we observed that both T and B lymphocytes
ere recruited to the vagina within 24 h after virus
hallenge in immune mice but not in nonimmune mice;
hat is, the kinetics of lymphocyte recruitment indicated
hat it involved a memory response (Parr and Parr,
998a). We confirmed and extended that observation in
he present study, finding that lymphocyte recruitment in
mmune mice was already well underway within 8 h after
aginal challenge and that the recruitment required
FN-g. Direct injection of IFN–g into the skin of nonim-
unized rats (Issekutz et al., 1988) and baboons (Munro
t al., 1989) caused migration of leukocytes into the
issue, and administration of anti–IFN–g to mice during
rimary infection with influenza virus inhibited leukocyte
nfiltration into the lungs (Baumgarth and Kelso, 1996).
imilarly, administration of anti–IFN–g in vivo caused a
0–90% inhibition of leukocyte recruitment into a site of
elayed–type hypersensitivity (Issekutz et al., 1988). In
ontrast, recruitment of T cells to the lungs of immune
ice challenged with influenza virus was reported to be
ot significantly different in normal and IFN–g–knockout
ice (Bot et al., 1998). We are not aware of any previous
tudies showing that IFN–g mediates rapid recruitment
f large numbers of T and B lymphocytes to a site of
ntigen challenge in immunized animals, and such re-
ls (a, arrow), CD81 T cells (b, arrow), and B2201 B cells (c, arrow) in
e with wild-type virus. The lymphocytes appear to be adhering to the
.T cel
allengruitment is not currently recognized as a function of
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290 PARR AND PARRFN–g (Dijkmans and Billiau, 1988; Nathan, 1992; Farrar
nd Schreiber, 1993; Springer, 1994; Billiau, 1996). Nev-
rtheless, our data clearly indicate that the IFN–g se-
reted by memory T cells in the vagina of immune mice
fter virus challenge was responsible for rapid recruit-
ent ('8 h) of large numbers ('30–fold increase) of
dditional T and B lymphocytes to the vagina.
Large numbers of T and B lymphocytes were present
n the small veins in the vagina of immune mice after
hallenge, but T cells were virtually absent from such
essels if the mice were pretreated with anti–IFN–g.
hus recruitment of T lymphocytes into the vagina by
FN–g appeared to involve the induction of adhesion
actors on the vascular endothelium. The adhesion mol-
cules ICAM–1 and VCAM–1 and their respective lym-
hocyte integrins LFA–1 and VLA–4 may play a role in
his experimental system because they mediate T lym-
hocyte recruitment into tissues (Dustin and Springer,
988; Baron et al., 1993; Perry et al., 1998); the adhesion
olecules may be upregulated on vascular endothelial
ells by IFN-g (Dustin et al., 1986; Yu et al., 1985; Ruszc-
ak et al., 1990; Wellicome et al., 1990; Bevilacqua, 1993;
echleitner et al., 1998); and in vivo administration of
onoclonal antibodies to LFA–1 and VLA–4 blocked the
T
Effects of in Vivo Neutralization of IFN
Micea
IFN-gb
(pg/ml)
MHC
class IIc
Lymphocytesd
CD41 CD81
mmune
No ascites 160 6 30 3.0 6 0.0 5.7 6 0.6 9.5 6 0.9
Yes ascites 0.33 6 0.3 0.0 6 0.0 0.19 6 0.07 0.15 6 0.06
onimmune
No ascites NA 0.0 6 0.0 NA NA
a Twenty-two immune (no ascites treatment), 24 immune (yes ascites
n each group, half of the mice were used at 24 h and half at 52 h afte
as administered (ip) 17 h before challenge.
b IFN-g concentration in 200-ml extracts of vaginal mucus 24 h after c
as not significantly different from 0.0, P 5 0.36, two-tailed t test.
c Staining of vaginal epithelial cells on a scale of 0–3 at 24 h after cha
rom each mouse was examined.
d Numbers of lymphocytes per high power microscopic field of vagin
rom each of two sections from two blocks from each mouse were co
e Log2.5 geometric mean titers 6 standard errors of the mean. Ascit
hallenge (P 5 0.63, Mann-Whitney U test), but titers were significantl
f Log2.5 geometric mean titers 6 standard errors of the mean, geom
n 200-ml extracts of vaginal mucus. Ascites treatment significantly incr
espectively, Mann-Whitney U tests) and significantly increased the num
.0002, respectively, one-tailed Fisher’s exact tests). The fact that litt
onsistent with previous results (Parr and Parr, 1998b) and indicates tha
nterpretation is consistent with the observation that the vaginal mucus
rotein measured in nonimmune mice and ascites-treated mice was
omparison of ascites-treated mice with nonimmune mice would be uFN–g–mediated recruitment of lymphocytes into the site pf a delayed–type hypersensitivity reaction (Chisholm et
l., 1993; Issekutz, 1993; Scheynius et al., 1993; Springer,
994).
MATERIALS AND METHODS
nimals and virus
Female BALB/c mice were purchased from Harlan/
prague–Dawley, Indianapolis, IN, and were 10–20
eeks old when used. They were housed in compliance
ith all institutional and federal animal welfare require-
ents, and all experimental procedures were approved
y the institutional Animal Care and Use Committee.
ild-type TK1HSV-2 and attenuated DTK2HSV-2, a strain
hat contains a partial deletion of the thymidine kinase
ene; HSV-2-infected Vero cell lysates; and uninfected
ero cell lysates were generously provided by Dr. Mark
cDermott, McMaster University, Hamilton, Canada
McDermott et al., 1984, 1987).
aginal immunization and challenge
Mice were immunized by pretreatment with 2.0 mg of
epo-Provera (DP) (Upjohn Co., Kalamazoo, MI) in phos-
Immunity to Vaginal HSV-2 Infection
IgG anti-HSV-2e Shed virus proteins f
Illness
scores01 24 h 52 h 24 h 52 h
1.1 5.8 6 0.4 5.9 6 0.4 0.95 6 0.5 0.90 6 0.5 0.0
2.4 (3/11) 2.3 (3/11)
0.5 5.7 6 0.6 7.2 6 0.4 5.2 6 0.7 6.6 6 0.5 0.0
120 (12/12) 420 (12/12)
A NA NA 5.5 6 0.6 9.9 6 0.3 3.0
150 (4/4) 8,700 (4/4)
nt), and 8 nonimmune mice were challenged ivag with wild-type virus.
nge. In the ascites-treated immune mice, 0.5 ml of anti-IFN-g ascites
e (mean 6 standard error of mean). The value in ascites-treated mice
(mean 6 standard error of mean). One section from each of two blocks
ma 24 h after challenge (mean 6 standard error of mean). Five fields
tment had no significant effect on titers in immune mice at 24 h after
sed in ascites-treated mice at 52 h (P 5 0.02, Mann-Whitney U test).
ean titers, and (proportion of mice with detectable shed virus protein)
shed virus protein titers at 24 h and 52 h (P 5 0.0005 and P , 0.0001
mice in which shed virus protein was detectable (P 5 0.0003 and P 5
protein was detected in immune mice without ascites treatment is
hallenge virus inoculum was cleared from the vagina within 24 h. This
on is completely replaced within 24 h (Parr et al., 1998). Thus the virus
replication of challenge virus in the vaginal epithelium. A statistical
le because of the small numbers of nonimmune mice used.ABLE 5
-g on
B22
10.6 6
2.6 6
N
treatme
r challe
halleng
llenge
al stro
unted.
es trea
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bers of
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291ROLE OF IFN-g IN IMMUNITY TO VAGINAL HSV-2 INFECTIONays later by intravaginal (ivag) inoculation of 20 ml of
ttenuated HSV-2 at 1.5 3 106 PFU/ml. Immune and
ge-matched nonimmune mice were challenged by pre-
reatment with DP as above, followed 6 days later by ivag
noculation of 10 ml of wild-type HSV-2 at 3.5 3 106
FU/ml.
aginal secretion
The vaginal lumen of progestin-treated mice is filled
ith mucus that is 97% water and has a volume of 10–15
l (Parr et al., 1998). The vaginal mucus was collected
nce from each mouse by pipetting 50 ml of Tris-buffered
aline (TBS) at pH 7.5 in and out of the vagina until the
ucus was recovered. The vagina was immediately
ashed with 50 ml of TBS again to ensure effective
ecovery of the vaginal secretions. Afterward the two
ashes were combined and frozen at 220°C until
eeded. The mucus was extracted by rotating thawed
amples at 15 rpm for 2 h at 4°C, followed by centrifu-
ation to pellet the mucus. The supernatant was recov-
red and replaced by 120 ml of fresh TBS, followed by
otation for 2 h at 4°C. The two mucus extracts were
ombined, brought to 0.05% Tween 20, adjusted to 200 ml
some TBS is absorbed by the mucus during extraction),
hen diluted with 200 ml of the casein-containing diluent
hat was used for all ELISA measurements (see below).
he resulting 400-ml samples from each mouse were
sed for all ELISA measurements, and measured con-
entrations and titers were doubled so that all results
efer to concentrations in the 200-ml extracts of vaginal
ucus. Because mucus volumes were 10–15 ml, concen-
rations in situ in the vagina were ;15-fold higher than
hose measured in the extracts.
easurement of IFN–g by ELISA
Capture antibody (monoclonal rat anti-mouse IFN-g,
lone R4–6A2 (Access Biomedical, San Diego, CA) at 6
g/ml was bound to white, high-binding (Costar, Cam-
ridge, MA) microtiter plate wells overnight in 0.10 M
arbonate buffer at pH 9.5. After being washed in PBS–
.05% Tween 20, plate wells were blocked for 5 h with
.20% casein (Tropix Inc., Bedford, MA) in PBS–0.10%
ween 20 at pH 6.8. Samples (100 ml), diluted as required
n PBS at pH 7.5 containing 0.20% casein and 0.05%
ween 20, were then placed in the wells and incubated
vernight at 4°C. After washing in PBS–Tween 20, bound
FN–g was detected with rabbit anti-mouse recombinant
FN–g (Biosource International, Inc., Camarillo, CA) in
ilution medium for 2 h, followed by washing in PBS–
ween 20 and incubation for 2 h in alkaline phosphatase-
onjugated goat anti-rabbit IgG (Zymed, San Francisco,
A) in dilution medium. After being washed in PBS–
ween 20, plate wells were incubated with 100 ml of
hemiluminescence substrate (CSPD with sapphire,
ropix Inc., Bedford, MA), followed by measurement in a ticrolite (R) ML2250 luminometer (Dynatech Laborato-
ies, Alexandria, VA). Recombinant dimeric mouse IFN–g
PharMingen, San Diego, CA, 10 IU/ng) was used as the
tandard and could be detected at 2.0 pg/ml and higher
sample mean larger than blank mean plus 3 standard
eviations). The IFN–g in vaginal secretions was stable
uring storage at 220°C, but its concentration declined
0–20% per day in extracts of vaginal mucus that were
tored at 4°C. Therefore IFN–g was always measured on
he day the vaginal mucus samples were thawed and
xtracted.
easurement of IgG anti-HSV-2 by ELISA
Microtiter plate wells (high-binding white plates,
ostar) were filled with 100 ml of UV-inactivated lysate
f HSV-2-infected Vero cells in carbonate buffer at pH
.5, covered with sealing film, centrifuged at 2700 rpm
or 2 h in a Beckman GS-6R centrifuge, and incubated
vernight at 4°C. On the next day, plate wells were
ashed with PBS–0.05% Tween 20 and blocked 5 h
ith 0.20% casein (Tropix Inc.) in PBS–0.10% Tween 20
t pH 6.8. Serial 2.5-fold dilutions of samples in PBS
ontaining 0.20% casein and 0.05% Tween 20 at pH 7.5
ere then placed in the wells and incubated overnight
t 4°C. After washing in PBS–Tween 20, the wells
eceived alkaline phosphatase-conjugated goat anti-
ouse IgG (Fc) (Jackson Immunoresearch Labs Inc.,
est Grove, PA) for 2 h, followed by washing and
ntroduction of substrate (CSPD with sapphire, Tropix).
uminescence was measured in a Microlite (R) ML
250 luminometer (Dynatech Laboratories, Alexandria,
A). The sample antibody titer was defined as the
eciprocal of the sample dilution at which the lumines-
ence declined to the mean value of nonimmune sam-
les at the same dilution plus 3 standard deviations.
og2.5 geometric mean titers and their standard errors
ere measured for each group and used to determine
he statistical significance of differences between
roups. Control measurements demonstrated that all
LISA reactions were at the same background level
hen immune and nonimmune samples were incu-
ated on lysates of uninfected Vero cells and when
onimmune samples were incubated on infected Vero
ells.
easurement of shed virus protein by ELISA
Shed virus protein was measured by ELISA in extracts
f vaginal mucus that was collected at 24 and 52 h after
aginal challenge with wild-type virus. The method was
imilar to that recently described by Franco and Green-
erg (1995) and Parr and Parr (1997). The resulting shed
irus protein titers are closely correlated with the per-
entage of the vaginal epithelium that is infected by the
irus, indicating that the method measures virus protein
hat is shed into the vaginal lumen from infected epithe-
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292 PARR AND PARRial cells (Parr and Parr, 1998b). The capture ELISA de-
cribed above for IFN-g was used with the following
odifications. The capture antibody was rabbit IgG anti-
SV-1 and 2 (Dako Corp., Carpinteria, CA) at 10 mg/ml.
or detection of captured virus proteins, the rabbit IgG
nti-HSV was conjugated to biotin-X-NHS (Calbiochem
orp., LaJolla, CA), and the biotinylated antibody was
etected with alkaline phosphatase-streptavidin (Pierce
hemical Co., Rockford, IL). Serial 2.5-fold dilutions of
he vaginal samples were measured. Titer was defined
s the reciprocal of the dilution at which the lumines-
ence declined to 3 standard deviations above the mean
ackground luminescence in wells containing samples
rom immune-nonchallenged mice at the same dilution.
og2.5 geometric mean titers and their standard errors
ere measured for each group and used to determine
he statistical significance of differences between
roups, and geometric mean titers are also presented
ecause they indicate more clearly the relative concen-
rations of shed virus proteins in the groups.
issues
For immunolabeling, vaginae from 10 nonimmune-
hallenged, 10 immune-challenged, and 10 immune-non-
hallenged mice were fixed with 2% paraformaldehyde in
.1 M phosphate buffer, pH 7.4 (4°C, 2 h), washed with
BS containing 10% sucrose (4°C, 2 h), embedded in
.C.T. (Tissue-Tek, Miles Scientific, Naperville, IL), frozen
n isopentane cooled with liquid nitrogen, and stored at
70°C until needed. Cryostat sections (5 mm) were
ounted on silanized slides, air dried, and stored with
esiccant at 220°C until needed. Sections from both
nds of each vagina were studied. For in situ hybridiza-
ion, 30 vaginae from the three mouse groups mentioned
bove were fixed in 4% paraformaldehyde (4°C, over-
ight) and embedded in paraffin. Sections from both
nds of each vagina were studied.
mmunolabeling of IFN-g
Tissue sections were blocked in 2% normal goat se-
um (30 min), incubated in rabbit anti-mouse IFN–g (60
in, 37°C, Biosource International Inc.), washed in PBS
10 min), treated with 0.5% hydrogen peroxide in metha-
ol, washed in PBS, incubated in biotinylated goat anti-
abbit IgG (1/150, 20 min, Vector Labs Inc., Burlingame,
A) followed by streptavidin peroxidase (10 min, Zymed
abs. Inc.), and exposed to substrate (AEC kit, Zymed
abs.). Tissue sections were then counterstained with
ill’s haematoxylin and mounted in Gelmount (Biomeda
orp., Foster City, CA). Specificity of labeling was indi-
ated by the absence of staining when irrelevant rabbit
gG antibodies were substituted for the primary antibody
y marked inhibition of labeling when primary antibody
as mixed with recombinant IFN–g (PharMingen) at 10 pg/ml prior to labeling and by absence of labeling in
ections from immune-nonchallenged mice.
FN-g in situ hybridization
A cDNA probe for interferon–g was generously sup-
lied by Genentech, Inc. (San Francisco, CA). The plas-
id (pms10) contained the cDNA inserted in the PstI site
f pBR322. The IFN–g cDNA served as a template for
olymerase-directed synthesis of digoxigenin-labeled
ntisense and sense cRNA (Genius Nucleic Acid Detec-
ion Kit, Boehringer-Mannheim Corp., Indianapolis, IN).
or in situ hybridization, tissue sections were deparaf-
inized, rehydrated in graded ethyl alcohols, treated with
mg/ml proteinase-K for 30 min at 37°C, and washed for
0 min in PBS, pH 7.2, containing 5 mM MgCl2. The
ections were prehybridized in 50% formamide/double-
trength standard sodium citrate buffer (SSC; 20-strength
SC contains 3 M NaCl and 0.3 M sodium citrate), pH 7.0,
t 66°C. Sections were incubated overnight at 47°C in a
umidified chamber with a hybridization cocktail contain-
ng 50% formamide, 10% dextran sulfate, 250 mg tRNA/ml,
nd 100 ng/ml of either antisense RNA IFN–g probe or
he sense version of the same probe for control sections.
fter hybridization, tissue sections were washed exten-
ively, concluding with 0.13 SSC at 47°C for 30 min.
ybridization was detected by incubating the sections
ith biotinylated anti-digoxigenin antibody (Sigma
hemical Co., St. Louis, MO) followed by treatment with
vidin conjugated to alkaline phosphatase (Sigma). In-
ubation in a substrate solution containing levamisole,
itroblue-tetrazolium, and 5-bromo, 4-chloro, 3-indolyl
hosphate (Promega, Madison, WI) yielded a brown re-
ction product at the site of hybridization between IFN–g
RNA and probe. Tissue sections were counterstained
ith nuclear fast red.
uantitation of lymphocytes
Cryostat sections were post-fixed 10 min in acetone,
locked 30 min in 2% goat serum, and incubated 1 h in
ne of the following primary antibodies: rat anti-mouse
D4 or CD8 (Becton Dickinson, Mountain View, CA) or
at anti-mouse B220 (ATCC, Rockville, MD). The second-
ry antibody was FITC-donkey anti-rat IgG (Chemicon
nternational, El Segundo, CA). Specificity of labeling was
ndicated by the absence of staining when normal rat IgG
as substituted for the primary antibodies. Lymphocytes
CD41, CD81, B2201) were counted in five randomly
elected high power fields from each of two separate
egions of vagina. The stained cells were counted in
aptured images using an image analysis system. A
igh-resolution RGB color camera with integration (AIC-
-VI 470, Hyper HAD CCD; Optronics Engineering, Go-
eta, CA) was attached to the fluorescence microscope.
aptured images were analyzed using a MacIntosh com-
uter (Quadra 840 AV) equipped with the LG-3 frame
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293ROLE OF IFN-g IN IMMUNITY TO VAGINAL HSV-2 INFECTIONrabber (Scion Corp. Frederick, MD) and using NIH Im-
ge 1.55 (Wayne Rasband, National Institutes of Health).
uantitation of MHC class II antigen staining in
aginal epithelium
Sections of vagina were stained as described above
or lymphocytes, using rat anti-mouse Ia (Boehringer-
annheim) as the primary antibody. The intensity of
taining in the vaginal epithelium was evaluated in two
oded sections from each mouse and recorded as none
0), weak (1), moderate (2), or bright (3), along with the
pproximate proportion of epithelium with each kind of
taining. All staining was evaluated in captured images.
n vivo depletion of IFN-g
Hybridoma cell line R4–6A2 (rat anti-murine IFN-g)
as purchased from ATCC. Ascites fluid containing the
onoclonal antibody was produced by TSD BioServices
Germantown, NY) by inoculating cultured hybridoma
ells into pristane-primed nude mice. The ascites fluids
ere collected, pooled, aliquoted, and stored at 270°C
ntil used. The concentration of rat IgG in the mouse
scites was measured in our laboratory by ELISA and
ound to be 2.0 mg/ml. Recombinant mouse IFN–g at 1.0
g/ml strongly inhibited the cytopathic effect of encepha-
omyocarditis virus in mouse L929 cells in vitro, and the
4–6A2 antibody at 1.0 mg/ml completely neutralized this
nti-viral effect of IFN-g. The latter assay was performed
y Access Biomedical.
llness scores
Illness was indicated by ruffled fur, arched backs,
eeble movements, paralysis of one or both hindlimbs,
nd by a swollen red vulva. An illness score of 3.0 was
ssigned to mice that died or became so ill that eutha-
asia was desirable by 9 days after challenge with wild-
ype virus. Mice that died or required euthanasia from 10
o 14 days after challenge were scored 2.0. Mice that
eveloped some sign of illness but survived beyond 14
ays were scored 1.0. Mice that never showed signs of
llness were scored 0.0.
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